| Original language | English |
|---|---|
| Pages (from-to) | 139-148 |
| Number of pages | 10 |
| Journal | Antiviral Therapy |
| Volume | 23 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 2018 |
Cite this
3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir. / Gagliardini, R.; Bandera, A.; Zaccarelli, M.; Sterrantino, G.; Latini, A.; D’Avino, A.; Lapadula, G.; Antinori, A.; Cauda, R.; De Luca, A.; Gori, A.; Giambenedetto, S.D.; Fabbiani, M.
In: Antiviral Therapy, Vol. 23, No. 2, 2018, p. 139-148.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - 3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir
AU - Gagliardini, R.
AU - Bandera, A.
AU - Zaccarelli, M.
AU - Sterrantino, G.
AU - Latini, A.
AU - D’Avino, A.
AU - Lapadula, G.
AU - Antinori, A.
AU - Cauda, R.
AU - De Luca, A.
AU - Gori, A.
AU - Giambenedetto, S.D.
AU - Fabbiani, M.
N1 - cited By 0
PY - 2018
Y1 - 2018
U2 - 10.3851/IMP3188
DO - 10.3851/IMP3188
M3 - Article
VL - 23
SP - 139
EP - 148
JO - Antiviral Therapy
JF - Antiviral Therapy
SN - 1359-6535
IS - 2
ER -